ixX pharma

What ixX pharma does

ixX Pharma is a Belgian nutraceutical manufacturer founded in 2005 by two scientists, headquartered in Antwerp, Belgium, and operating as a subsidiary of HAVEA GROUP. The company develops and markets a portfolio of 96+ scientifically-formulated nutritional supplements spanning vitamins and multivitamins (D-IXX, MULT-IXX, C-IXX, B-IXX), omega-3 (ZENIXX), sleep and stress (SERENIXX, KALM-IXX, MELATONINE-IXX), joints and inflammatory response (J-IXX, PEA-IXX), nervous system (NERIXX, LIPONIXX, MEGRIXX), energy and vitality (TONIXX), iron (FERIXX, KIDIXX FE), and pediatric formulations. Core technology centers on active-ingredient selection and dosing grounded in scientific literature, optimized bioavailability (e.g., MCT-coconut-oil matrices, micro-encapsulated iron, oil-based vitamin D delivery formats), and an internal control laboratory performing daily microbiological and physicochemical analyses; production is carried out at HAVEA GROUP's FSSC 22000-certified facility in France. ixX Pharma pioneered the Belgian-market introduction of novel ingredients including β-glucan, PEA (palmitoylethanolamide), AKBA, and PQQ (pyrroloquinoline quinone).

The business runs a B2B2C go-to-market model. Demand is generated through healthcare professionals — doctors, pharmacists, and micronutrition practitioners — via scientific webinars, scientific evenings led by founder Dr. Danny Bral (PhD in biochemistry), and detailed professional support materials; off-take flows through Belgian pharmacies and health retailers, with end consumers purchasing branded supplements for sleep, stress, immunity, vitality, beauty, muscles/joints, and children's health needs. The company markets itself as a science-driven pioneer and content publisher via the 'Focus santé' health-information blog. Pricing is not publicly disclosed, products are positioned as premium differentiated formulations rather than commodity vitamins, and revenue is generated through one-time product sales. The company is privately held under HAVEA GROUP, with no independent institutional investors or public ownership identified.

Operationally, ixX Pharma employs 11-50 people, serves exclusively the Belgian market per available data, and is registered as IXX PHARMA under company number 0873.490.740. Its stated competitive logic is to combine scientific rigor, ingredient novelty, certified manufacturing, and practitioner-led recommendation to defend a specialist positioning inside the Belgian pharmacy channel against larger OTC nutraceutical brands.

Name

ixX pharma

Legal name

IXX PHARMA

Website

https://ixx.be

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

ixX Pharma is a Belgian nutraceutical company, founded in 2005 and part of HAVEA GROUP, that develops and markets 96+ scientifically-formulated vitamin, mineral, omega-3, and specialty supplements through Belgian pharmacies and health retailers, with demand driven by healthcare professional recommendations.

Ownership category

akta.pro rank

Product category

Nutritional Supplements

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

akta.pro secondary industry

Multivitamins & Daily Packs (CRADAGAC)

Keywords

• Nutritional supplements
• Vitamin formulations
• Micronutrition products
• Dietary supplements
• Pharmaceutical-grade supplements

Headquarters

HQ city

Nieuwkerken-waas

HQ country

Belgium

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Nutritional supplement sales: ixX Pharma generates revenue through the sale of nutritional supplements targeting various health needs including sleep, stress, immunity, nervous system support, muscles and joints, beauty, and general vitality. Products are sold through pharmacies, health retailers, and potentially direct-to-consumer channels.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

ixX Pharma manufactures and markets scientifically-formulated nutritional supplements including vitamins, minerals, omega-3 fatty acids, amino acids, plant extracts, and endogenous substances, distributed through Belgian pharmacies and health retailers. The portfolio of 96+ products is organized by health need (sleep, stress, immunity, muscles and joints, beauty, vitality, digestion, children's health) and emphasizes formulations with optimized bioavailability backed by scientific literature.

Product overview

ixX Pharma is a Belgian dietary supplement company founded in 2005, specializing in scientifically-formulated natural health solutions. The product portfolio consists of multiple supplement lines organized by health need: Vitamin D supplements (D-IXX series including 1000, 2000, 3000, 3000 ZINC, 3000 VEGAN, LIQUID, ULTRA); Multivitamins (MULT-IXX, MULT-IXX KIDZ, MULT-IXX GUMMIES); Energy and vitality (TONIXX GOLD, TONIXX B-ACTV'); Nervous system support (NERIXX, LIPONIXX, MEGRIXX); Sleep and stress management (SERENIXX, KALM-IXX, MELATONINE-IXX, KIDIXX SLEEP); Muscles and joints (PEA-IXX, PEA-IXX PLUS, J-IXX, J-IXX INTENSE, J-IXX PREMIUM); Omega-3 (ZENIXX PREMIUM, ZENIXX GOLD, ZENIXX 500D, ZENIXX PLUS, ZENIXX KIDZ D); Vitamins C and B (C-IXX, C-IXX KIDZ, B-IXX, BIMUNIXX); Iron supplements (FERIXX LIQUID, FERIXX ULTRA 45, KIDIXX FE); and specialized products (ARNIXX, ALLER-IXX). The company emphasizes scientific research-backed formulations with optimized bioavailability.

Differentiator

Problem solved

Functional benefit

Products and services

• D-IXX 1000®

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• HAVEA GROUPcoreOthersHAVEA GROUP is the parent company of ixX Pharma. The group processes customer data collected through contact forms and manages commercial communications. The production facility is located in France under HAVEA GROUP operations and holds FSSC 22000 certification. Contact data for data protection inquiries is [email protected].

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Arkopharma: European leader in plant-based (botanical) pharmaceutical and dietary supplements distributed heavily through pharmacies, with overlapping reliance on botanical ingredients and HCP endorsement in the Belgian market.
• Nutergia: French nutritional health laboratory marketing condition-specific supplements (omega-3, magnesium, micronutrition) through pharmacy networks with physician- and pharmacist-endorsed education, directly comparable to ixX Pharma's approach.
• Tilman: Belgian pharmaceutical laboratory specialised in plant-based medicinal and herbal supplements sold through Belgian pharmacies, overlapping on condition-specific botanical formulations and pharmacy distribution.
• Forté Pharma: Belgian-founded European nutraceuticals laboratory with broad ranges of vitamins, minerals, sleep/stress, slimming and detox products sold through pharmacies and parapharmacies, making it the closest Belgian-headquartered benchmark.
• Synergia: Belgian nutraceutical laboratory producing micronutrition and phyto-based supplements for pharmacy distribution, with comparable health-condition segmentation in the Belgian market.
• Pileje: French science-led nutraceutical company selling micronutrition and phytotherapy supplements primarily through pharmacies and HCPs, with a comparable health-condition SKUs and HCP-recognition-driven GTM in Belgium's neighbouring market.

Broad incumbents

• Metagenics: International nutritional supplement company targeting healthcare practitioners with evidence-based condition-specific formulations; broader portfolio and geographies than ixX Pharma but overlapping science-led HCP-recognition model.
• Biocodex: French family-owned pharmaceutical/health company with consumer health and nutraceutical lines distributed through French and Belgian pharmacies, sharing the science-grade, pharmacy-channel go-to-market with ixX Pharma but at significantly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ixX pharma